H

HOOKIPA Pharma
D

HOOK

2.17000
USD
0.04
(1.88%)
Market Open
Volume
950
EPS
-3
Div Yield
-
P/E
-1
Market Cap
26,158,350
Related Instruments
    AMZN
    AMZN
    -8.930
    (-4.22%)
    200.63 USD
    COST
    COST
    -17.04
    (-1.84%)
    953.41 USD
    D
    DKS
    -0.450
    (-0.23%)
    198.210 USD
    F
    FL
    -0.150
    (-0.63%)
    23.600 USD
    NKE
    NKE
    1.000
    (1.32%)
    79.38 USD
    S
    SPWH
    0.03000
    (1.35%)
    2.25000 USD
    TGT
    TGT
    -1.245
    (-0.81%)
    152.185 USD
    WMT
    WMT
    -0.220
    (-0.26%)
    89.63 USD
    More
News

Title: HOOKIPA Pharma Inc.

Sector: Healthcare
Industry: Biotechnology
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.